Understanding the Prescription Drug Access Challenge
Prescription drug coverage has become increasingly restrictive across all major insurance types, creating significant barriers for American patients seeking essential medications. Recent research reveals that healthcare consumers face unprecedented…
Patent Monopolies Drive Record Profits
Novo Nordisk and Eli Lilly have transformed GLP-1 receptor agonists into unprecedented profit machines. These blockbuster drugs, approved for diabetes and weight loss, generate billions while leaving many patients unable…
What You Should Know:
– Photon Health (“Photon”), a prescription network focused on patient choice and transparency announced a collaboration with Amazon Pharmacy, the digital-first online pharmacy known for price transparency and medication access.
– The…
Continue Reading
Transforming Electronic Prescribing Through Price Transparency
DoseSpot, a leading electronic prescribing platform, is revolutionizing how patients access their medications with the launch of DoseSpot Connect. This innovative product suite represents a significant leap forward in…
Yoona Kim, Founder & CEO at Arine
As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or…
Continue Reading
Patty Trainor, Sr. Director KS&R
Infusion Clinics (ICs) face a delicate balancing act. They must strive for operational excellence while simultaneously navigating the realities of competition, patient care challenges, and compliance requirements. It’s a difficult…
Continue Reading
What You Should Know:
–TailorMed, a leading innovator in healthcare technology, announced a $40 million financing round combining equity and debt. This investment positions the company to advance its bold vision of transforming medication access,…
Continue Reading
From Jaded CMIO: “Re your recent comments about the Medication Access and Training Expansion Act (MATE) and its 8-hour DEA education requirement being a time waster. I’m in the same boat – I don’t…
Continue Reading
Truveris, a health technology company focused on decreasing prescription costs for employers and their members, announced it secured $15 million in Series E investment. Existing investors Canaan Partners and New Leaf Venture Partners led the…
Continue Reading
By Anuja Vaidya
March 06, 2024 – Regulatory flexibilities enabling virtual initiation and at-home doses of medications for opioid use disorder (OUD) are likely cost-effective, according to new research.
Published in the journal Drug and Alcohol Dependence,…
Continue Reading
